Compare Apollo Global Management Ord Shs (APO) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apollo Global Management Ord Shs vs Ginkgo Bioworks Holdings Inc — how do they compare? Apollo Global Management Ord Shs trades at $140.98 (market cap $82.84B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Apollo Global Management Ord Shs is far larger — about 163.8× Ginkgo Bioworks Holdings Inc's market cap, and Apollo Global Management Ord Shs pays a 1.6% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| APO | DNA | |
|---|---|---|
Market Cap | $82.84B | $505.73M |
Sector | Financials | Health |
52-Week High | $152.70 | $16.14 |
52-Week Low | $100.30 | $5.48 |
Enterprise Value | -$168.65B | $607.68M |
Dividend Yield | 1.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apollo Global Management Ord Shs
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Private Equity, Credit, and Real Assets. It generates maximum revenue from the Credit segment in the form of fees. The credit segment primarily invests in non-control corporate and structured debt instruments including performing, stressed and distressed instruments across the capital structure. It also includes Corporate Credit
Read more on APO →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
